New POC Device Delivers CBC Results in 8 Minutes

The Complete Blood Count (CBC) is one of the most common lab tests in the U.S., with an estimated 500 million performed annually. Traditionally, results from central labs can take anywhere from 45 minutes to over 24 hours, creating diagnostic bottlenecks, particularly in urgent care settings. Point-of-care (POC) testing directly addresses this delay. Studies have shown that implementing POC CBC analysis in the emergency department can reduce the median time to medical decision-making by nearly 100 minutes and shorten the total length of stay by over 150 minutes. This accelerated diagnostic capability is driven by competitors like PixCell Medical, whose HemoScreen analyzer delivers 5-part differential CBC results from a single drop of blood in five minutes. Another key player, Sysmex, offers the CLIA-waived XW-100, which also significantly reduces wait times for critical blood level information needed to diagnose infections or severe anemia. The operational impact extends beyond speed. For hospital systems, faster turnaround times are linked to more efficient use of staff and space, and a reduction in the number of patients who leave the emergency department without being seen. This helps alleviate the strain of rising patient volumes, which saw average emergency department wait times climb to 162 minutes in 2022. From a financial perspective, the integration of POC CBC testing can be cost-effective. While individual test costs may vary, the overall value proposition includes savings on labor and the economic benefits of improved patient throughput. Some analyses show that POC testing for a CBC and metabolic panel can ultimately save money when factoring in the value of time saved. The global market for hematology analyzers reflects this shift, with a valuation of $3.78 billion in 2024 and projected growth driven by demand for faster, more accurate diagnostics. North America currently represents the largest market share, at approximately 40%, indicating a high adoption rate of these advanced diagnostic technologies.